Effects of pioglitazone on subclinical atherosclerosis and insulin resistance in nondiabetic renal allograft recipients | Zendy

Seung Jin Han | Zendy; Kyu Yeon Hur | Zendy; Yu Seun Kim | Zendy; Eun Seok Kang | Zendy; Soon Il Kim | Zendy; Myoung Soo Kim | Zendy; Jin Young Kwak | Zendy; Dae Jung Kim | Zendy; Sung Hee Choi | Zendy; Bong Soo | Zendy; H. C. Lee | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effects of pioglitazone on subclinical atherosclerosis and insulin resistance in nondiabetic renal allograft recipients

Author(s) -

Seung Jin Han,

Kyu Yeon Hur,

Yu Seun Kim,

Eun Seok Kang,

Soon Il Kim,

Myoung Soo Kim,

Jin Young Kwak,

Dae Jung Kim,

Sung Hee Choi,

Bong Soo,

H. C. Lee

Publication year - 2009

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfp567

Subject(s) - pioglitazone , medicine , insulin resistance , adiponectin , intima media thickness , insulin , endocrinology , diabetes mellitus , transplantation , urology , type 2 diabetes , carotid arteries

The aim of this study was to evaluate the effect of pioglitazone treatment on the progression of subclinical atherosclerosis and insulin resistance in renal allograft recipients with no preoperative history of diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research